FDA Update August 4, 2017
Congress passes FDA Reauthorization Act (FDARA) of 2017 A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes was passed by the Congress on August 3, 2017. The federal budget process occurs